Classification of CD4+ T helper cell clones in human melanoma

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Tumor-infiltrating lymphocytes (TILs) are crucial for anti-tumor immunity.
• Understanding TIL subsets and their function is key to developing effective cancer immunotherapies.
• Previous methods generated TIL clones from renal cell cancer without specific subset selection.

Purpose of the Study:

• To generate and characterize CD4+ and CD8+ TIL clones from melanoma patients.
• To assess the cytokine production profiles of these TIL clones.
• To investigate the responsiveness of TIL clones to autologous tumor cells.

Main Methods:

• Generation of TIL clones using solid-phase anti-CD3 antibody activation and expansion with IL-2 and irradiated allogeneic B cells.
• Characterization of TIL clones for T cell subset (CD4+, CD8+).
• Assessment of cytolytic activity via antibody-redirected lysis (ARL).
• Quantification of IL-2, IL-4, and IFN-gamma production following anti-CD3 or autologous tumor cell stimulation.

Main Results:

• 66 CD4+ and 36 CD8+ TIL clones were generated from five melanoma patients.
• All CD8+ TIL clones exhibited strong cytolytic activity, while 85% of CD4+ TIL clones did not.
• CD8+ clones produced IFN-gamma, minimal IL-2, and no IL-4.
• CD4+ clones were classified as Th0 (66%), Th1 (15%), or Th2 (19%).
• Few TIL clones, particularly CD8+ and T helper cells, responded to autologous tumor cells by producing cytokines.

Conclusions:

• Melanoma TILs primarily consist of IL-2-producing Th0 cells.
• A significant proportion of generated TIL clones do not exhibit robust responses to autologous tumor cells.
• These findings highlight potential challenges in T cell-mediated anti-tumor responses in melanoma.